Fidelity and Polaris’s investments in biotech and cancer immunotherapy startups
Fidelity Investments and Polaris Partners have both mad … 阅读更多
cancer
CD93, a promising emerging target for cancer immunotherapy and vascular normalization
CD93 is a transmembrane protein that has been found to … 阅读更多